Intervertebral Disc Displacement, Sciatica, Sciatic Radiculopathy
Conditions
Keywords
Complementary Therapies, Exercise, Acupuncture
Brief summary
A prospective pilot study will be conducted to investigate the effectiveness and safety in herniated lumbar disc (HLD) patients receiving integrative Korean medicine treatment including Doin (conduction exercise) at a Korean medicine hospital through assessment of pain, functional disability, and quality of life.
Detailed description
A prospective single-center observational pilot study will be conducted to investigate the effectiveness and safety in herniated lumbar disc (HLD) patients with radiating leg pain receiving integrative Korean medicine treatment including Doin (conduction exercise) of the pelvic joint at Daejeon Jaseng Hospital of Korean Medicine through assessment of pain, functional disability, quality of life, satisfaction, and safety. The study is expected to be performed over a period of 6 months, during the former 3 months of the study period of which the Integrative Korean medicine treatment group will be recruited, and after a wash-out period of 2 weeks, during the latter 3 months of the study period of which the Doin with integrative Korean medicine will be recruited separately.
Interventions
PROCEDUREDoin (conduction exercise)
An acupuncture physician will administer acupuncture at 4-8 acupoints in the low back and gluteal area (mandatory points: BL54, and GB30 ipsilateral to the dysfunctional site; and selective points: BL23, BL24, BL25, BL26, BL31, BL32, Ah-shi points, local acupuncture points and/or trigger points. Doin (conduction exercise) will be performed as active and passive movement with the needles in situ to the aim of effective treatment of pain and functional disability by increasing the hip joint range of motion (flexion and extension) with physician guidance and isometric resistance exercise (flexion and extension) as needed. Doin (conduction exercise) sessions will be performed 1 session/day for the duration of hospitalized treatment while the patient presents radiating leg pain (NRS≥1).
DRUGHerbal medicine
Herbal medicine will be mainly administered in water-based decoction (120ml) and dried powder (2g) form (the ingredients are mainly, but not restricted to: Ostericum koreanum, Eucommia ulmoides, Acanthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, Saposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycine max, Atractylodes japonica).
PROCEDUREChuna manual therapy
Chuna is a Korean spinal manipulation that incorporates spinal manipulation techniques for joint mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manipulation will be administered at the physician's discretion.
PROCEDUREBee venom pharmacopuncture
Bee venom pharmacopuncture will be administered only after confirming a negative response to hypersensitivity skin test. Diluted bee venom (saline:bee venom ratio, 10,000:1) filtered for allergens will be injected at 4-5 acupoints proximal to the dysfunctional site at the physician's discretion. Each acupuncture point will be injected to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).
PROCEDUREPharmacopuncture
Pharmacopuncture consisting of select herbal ingredients will be administered at Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).
PROCEDUREAcupuncture
Acupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.
PROCEDUREElectroacupuncture
Electroacupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.
PROCEDURECupping
Cupping treatment will be administered at 1-2 points using mainly proximal acupuncture points and Ah-shi points.
Patients will be allowed any other additional intervention(s) as deemed necessary by the attending physician regardless of type or dose, and patterns of use will be investigated and recorded as an pragmatic clinical study.
Sponsors
Jaseng Medical Foundation
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
19 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Inpatients with radiating leg pain distal to the gluteal fold with or without low back pain (LBP) * Patients with onset of radiating leg pain occurrence within the last six months, and current pain intensity of numeric rating scale (NRS) ≥5 * Patients with disc protrusion or extrusion at the neural segment level with significant correlations with the radiating leg pain symptoms as identified on L-spine magnetic resonance imaging (MRI) * Patients with plans of receiving Korean medicine treatment for herniated lumbar disc (HLD) through hospitalized care * Patients who give voluntary written informed consent to study participation
Exclusion criteria
* Patients with other systemic diseases that may interfere with treatment effect or outcome interpretation * Surgery and surgical procedure in the last three weeks in areas of clinical relevance as a result of HLD * Patients with soft tissue pathologies or pathologies of non-spinal origin that may cause LBP or radiating leg pain (e.g. spinal tumor, rheumatoid arthritis) * Patients for whom acupuncture treatment may be inappropriate or unsafe (e.g. hemorrhagic diseases, blood clotting disorders, history of anti-coagulation medicine intake, serious diabetes with risk of infection, severe cardiovascular diseases, or other conditions deemed unsuitable for acupuncture treatment) * Pregnant patients or patients planning pregnancy * Patients with serious psychological disorders * Participating in other clinical studies other than observational studies * Patients unable to fill out study participation consent form * Subjects deemed unsuitable for study participation as assessed by the researchers
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Numeric Rating Scale (NRS) of low back pain | Baseline, 2 weeks post-baseline | Change in low back pain intensity at 2 weeks as measured using NRS. In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'. |
| Change in Numeric Rating Scale (NRS) of radiating leg pain | Baseline, 2 weeks post-baseline | Change in radiating leg pain intensity at 2 weeks as measured using NRS. In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'. |
| Change in Oswestry Disability Index (ODI) | Baseline, 2 weeks post-baseline | Functional disability questionnaire at 2 weeks as measured using ODI. The ODI is a 10-item questionnaire developed to assess level of disability due to low back pain (LBP). Each item is graded into 6 levels, each representing a score of 0-5. Higher scores indicate greater limitation relating to LBP. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Numeric Rating Scale (NRS) of radiating leg pain | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Radiating leg pain intensity as measured using NRS. In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'. |
| Oswestry Disability Index (ODI) | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Functional disability questionnaire as measured using ODI. The ODI is a 10-item questionnaire developed to assess level of disability due to low back pain (LBP). Each item is graded into 6 levels, each representing a score of 0-5. Higher scores indicate greater limitation relating to LBP. |
| Visual Analogue Scale (VAS) of radiating leg pain | Baseline, 3, 7, 10, 14 days post-baseline | Radiating leg pain intensity as measured using VAS. VAS uses a 10cm line labeled at each end with scale anchors. In pain measurement using VAS, patients are asked to mark a point that represents their pain between the anchors of 'no pain' and 'worst pain possible' (labels may vary by study). Scores are recorded in millimeters with a total range of 0-100 millimeters. |
| Visual Analogue Scale (VAS) of low back pain | Baseline, 3, 7, 10, 14 days post-baseline | Low back pain intensity as measured using VAS. VAS uses a 10cm line labeled at each end with scale anchors. In pain measurement using VAS, patients are asked to mark a point that represents their pain between the anchors of 'no pain' and 'worst pain possible' (labels may vary by study). Scores are recorded in millimeters with a total range of 0-100 millimeters. |
| EuroQol 5-Dimension (EQ-5D) | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Health-related quality of life questionnaire as measured using SF-36. SF-36 consists of 36 items across 8 domains: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health. SF-36 is used to rate functional health and well-being in patients and healthy individuals. Higher scores indicate better HRQoL. |
| Patient Global Impression of Change (PGIC) | Baseline, 14, 30, 90 days post-baseline | Global patient-reported outcome as measured using PGIC. PGIC grades the level of subjective improvement into 7 levels (1, very much improved; 2, much improved; 3, slightly improved; 4, no change; 5, slightly worse; 6, much worse; and 7, very much worse). |
| Drug Consumption (drug type) | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Regarding recent use of medication, the type of prescription intake for medicine will be recorded. |
| Straight leg raise (SLR) test | Baseline, 3, 7, 10, 14 days post-baseline | Physical examination |
| Drug Consumption (drug intake period) | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Regarding recent use of medication, the period of prescription intake for medicine will be recorded. |
| Use of additional medical treatment (treatment type) | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Regarding current use of medical services, the type of additional medical treatment received will be recorded. |
| Use of additional medical treatment (treatment frequency) | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Regarding current use of medical services, the frequency of additional medical treatment received will be recorded. |
| Use of additional medical treatment (treatment period) | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Regarding current use of medical services, the period of additional medical treatment received will be recorded. |
| Details of Doin conduction exercise sessions (type (region)) | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Administration details of Doin conduction exercise session type (region) will be recorded. |
| Details of Doin conduction exercise sessions (period) | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Administration details of Doin conduction exercise sessions (period) will be recorded. |
| Lumbar range of movement (ROM) | Baseline, 3, 7, 10, 14 days post-baseline | Physical examination |
| Drug Consumption (drug intake frequency) | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Regarding recent use of medication, the frequency of prescription intake for medicine will be recorded. |
| Adverse events | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Safety outcome |
| Numeric Rating Scale (NRS) of low back pain | Baseline, 3, 7, 10, 14, 30, 90 days post-baseline | Low back pain intensity as measured using NRS. In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'. |
Countries
South Korea
Outcome results
None listed